JP2023545372A5 - - Google Patents
Info
- Publication number
- JP2023545372A5 JP2023545372A5 JP2023518752A JP2023518752A JP2023545372A5 JP 2023545372 A5 JP2023545372 A5 JP 2023545372A5 JP 2023518752 A JP2023518752 A JP 2023518752A JP 2023518752 A JP2023518752 A JP 2023518752A JP 2023545372 A5 JP2023545372 A5 JP 2023545372A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- subject
- hypomania
- mania
- dexmedetomidine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063089135P | 2020-10-08 | 2020-10-08 | |
| US63/089,135 | 2020-10-08 | ||
| PCT/US2021/054171 WO2022076818A1 (en) | 2020-10-08 | 2021-10-08 | Treatment of bipolar disorders and psychosis using dexmedetomidine hydrochloride |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023545372A JP2023545372A (ja) | 2023-10-30 |
| JP2023545372A5 true JP2023545372A5 (cg-RX-API-DMAC7.html) | 2024-10-15 |
Family
ID=81126063
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023518752A Pending JP2023545372A (ja) | 2020-10-08 | 2021-10-08 | デクスメデトミジン塩酸塩を用いた双極性障害及び精神病の治療 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240024289A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4225305A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023545372A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230084186A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116615243A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021356687A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3195133A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL301971A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023003993A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202228682A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022076818A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL267689B2 (en) | 2016-12-31 | 2025-05-01 | Bioxcel Therapeutics Inc | Use of sublingual dexmedetomidine for the treatment of agitation |
| IL279713B2 (en) | 2018-06-27 | 2025-01-01 | Bioxcel Therapeutics Inc | Dexmedetomidine-containing layer compositions and methods for their production |
| EP3999058A4 (en) | 2019-07-19 | 2023-05-03 | Bioxcel Therapeutics, Inc. | TREATMENT SCHEMES FOR NON-SEDATING DEXMEDETOMIDIN |
| EP4297871A4 (en) * | 2021-02-26 | 2025-01-01 | BioXcel Therapeutics, Inc. | METHODS AND COMPOSITIONS FOR TREATING AGITATION |
| US11806334B1 (en) | 2023-01-12 | 2023-11-07 | Bioxcel Therapeutics, Inc. | Non-sedating dexmedetomidine treatment regimens |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8242158B1 (en) * | 2012-01-04 | 2012-08-14 | Hospira, Inc. | Dexmedetomidine premix formulation |
| MX368880B (es) * | 2012-10-15 | 2019-10-21 | Orion Corp | Dexmedetomidina y medetomidina para su uso en el alivio de la aversión al ruido en un animal. |
| TWI624278B (zh) * | 2013-10-07 | 2018-05-21 | 帝國製藥美國股份有限公司 | 使用非鎮靜性右美托咪啶經皮組成物用於治療戒斷症候群的方法及組成物 |
| IL267689B2 (en) * | 2016-12-31 | 2025-05-01 | Bioxcel Therapeutics Inc | Use of sublingual dexmedetomidine for the treatment of agitation |
| EP3999058A4 (en) * | 2019-07-19 | 2023-05-03 | Bioxcel Therapeutics, Inc. | TREATMENT SCHEMES FOR NON-SEDATING DEXMEDETOMIDIN |
-
2021
- 2021-10-08 JP JP2023518752A patent/JP2023545372A/ja active Pending
- 2021-10-08 CA CA3195133A patent/CA3195133A1/en active Pending
- 2021-10-08 TW TW110137597A patent/TW202228682A/zh unknown
- 2021-10-08 US US18/030,405 patent/US20240024289A1/en not_active Abandoned
- 2021-10-08 AU AU2021356687A patent/AU2021356687A1/en not_active Abandoned
- 2021-10-08 CN CN202180069020.2A patent/CN116615243A/zh active Pending
- 2021-10-08 MX MX2023003993A patent/MX2023003993A/es unknown
- 2021-10-08 WO PCT/US2021/054171 patent/WO2022076818A1/en not_active Ceased
- 2021-10-08 EP EP21878615.0A patent/EP4225305A4/en not_active Withdrawn
- 2021-10-08 KR KR1020237013556A patent/KR20230084186A/ko not_active Withdrawn
- 2021-10-08 IL IL301971A patent/IL301971A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025092508A5 (cg-RX-API-DMAC7.html) | ||
| JP2023041862A5 (cg-RX-API-DMAC7.html) | ||
| JP2024109585A5 (cg-RX-API-DMAC7.html) | ||
| JP2022191257A5 (cg-RX-API-DMAC7.html) | ||
| BR9814378A (pt) | Forma de dosagem de liberação prolongada farmacêutica revestida entérica de um inibidor de h+, k+-atpase, processos para a manufatura da mesma, para melhorar a inibição de secreção de ácido gástrico, para melhorar o efeito terapêutico no tratamento de distúrbios gastrointentinais, para receber um perfil de plasma prolongado de um inibidor da h+, k+-atpase, e, usos de uma composição farmacêutica e de inibidor da h+, k+-atpase | |
| TWI455723B (zh) | 納曲酮及安非他酮於治療超重或肥胖病患之用途 | |
| JP2024540183A5 (cg-RX-API-DMAC7.html) | ||
| ATE350040T1 (de) | Stabilisierte pharmazeutische zusammensetzung enthaltend einen nichtsteroiden entzündungshemmenden wirkstoff und prostaglandin | |
| JP2025020117A5 (cg-RX-API-DMAC7.html) | ||
| JP2022163049A5 (cg-RX-API-DMAC7.html) | ||
| JP2021152008A5 (cg-RX-API-DMAC7.html) | ||
| JP2023175694A5 (cg-RX-API-DMAC7.html) | ||
| FI3746126T3 (fi) | Menetelmiä ja koostumuksia uniapnean tai pelkän kuorsauksen hoitamiseksi | |
| JP2005507892A5 (cg-RX-API-DMAC7.html) | ||
| JP2002528502A5 (cg-RX-API-DMAC7.html) | ||
| JP2005508963A5 (cg-RX-API-DMAC7.html) | ||
| JP2021073257A5 (cg-RX-API-DMAC7.html) | ||
| MX2024010637A (es) | Nuevas combinaciones terapeuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas. | |
| JP2025508004A5 (cg-RX-API-DMAC7.html) | ||
| JP2023531675A5 (cg-RX-API-DMAC7.html) | ||
| JP2007509146A5 (cg-RX-API-DMAC7.html) | ||
| JP2019514990A5 (cg-RX-API-DMAC7.html) | ||
| JP2022551691A5 (cg-RX-API-DMAC7.html) | ||
| JP2024514112A5 (cg-RX-API-DMAC7.html) | ||
| JP2023553253A5 (cg-RX-API-DMAC7.html) |